Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Clinics in New Mexico

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

What New Mexico law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and listings with their verification status.

New Mexico at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async not allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Clinics serving New Mexico

No verified clinics serving New Mexico are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in New Mexico

Yes. A New Mexico resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a New Mexico-licensed prescriber, including by telehealth. The New Mexico Telehealth Act (NMSA 1978, sections 24-25-1 to 24-25-7) defines telehealth to include interactive audio and video and store-and-forward technology, but it leaves prescribing standards to the licensing boards. New Mexico Medical Board rule 16.10.8.8(L) NMAC bars prescribing based solely on an online questionnaire, and its only telehealth exception is a face-to-face encounter by videoconference. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the New Mexico Board of Pharmacy; out-of-state pharmacies need a New Mexico nonresident pharmacy license, and nonresident pharmacies that ship sterile compounded preparations such as injectable peptides apply under a separate nonresident sterile application tied to the Board's sterile compounding rule, 16.19.36 NMAC. [1] [2] [3] [4] [5] [6] [7] [8] [9] [12]

Compounded GLP-1 access in New Mexico

Because compounded GLP-1 injections are sterile preparations, an out-of-state pharmacy shipping them into New Mexico must hold the Board's nonresident sterile licensure and meet 16.19.36 NMAC standards. [8] [9] [13]

Research use only sellers in New Mexico

The New Mexico Drug, Device and Cosmetic Act (NMSA 1978, sections 26-1-1 and following) prohibits selling adulterated or misbranded drugs and limits dispensing of dangerous drugs to licensed practitioners and pharmacies. [10] [14]

New Mexico notes on specific peptides

  • Tirzepatide: Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and any compounded injection must be prepared under 16.19.36 NMAC or an equivalent nonresident sterile license. [8] [13]

How to check a clinic in New Mexico

  1. Confirm the prescribing clinician's license with the New Mexico medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the New Mexico Board of Pharmacy (Regulation and Licensing Department) license lookup. [1] [2] [3] [8] [9] [12]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in New Mexico. [10] [14]

Common questions in New Mexico

Can I get a GLP-1 prescription in New Mexico through telehealth?

Yes, from a New Mexico-licensed prescriber. Semaglutide and tirzepatide are not controlled substances. The New Mexico Telehealth Act leaves the prescribing standard to the prescriber's licensing board. For physicians and physician assistants, New Mexico Medical Board rule 16.10.8.8(L) NMAC does not allow prescribing based solely on an online questionnaire, and its only telehealth exception is a face-to-face encounter using standard videoconferencing technology. A new telehealth patient should expect a live video visit. [4] [6] [7] [11]

All peptide legal questions for New Mexico

Sources

  1. [1]New Mexico Board of Pharmacy (Regulation and Licensing Department)
  2. [2]NMSA 1978, section 61-11-2, Pharmacy Act definitions (nonresident pharmacy)
  3. [3]NMSA 1978, section 61-11-14, Pharmacy licensure; classes of licenses; requirements; fees; revocation
  4. [4]New Mexico Telehealth Act, NMSA 1978, Chapter 24, Article 25
  5. [5]NMSA 1978, section 24-25-3, Telehealth Act definitions
  6. [6]NMSA 1978, section 24-25-5, Telehealth Act scope of act
  7. [7]16.10.8 NMAC, Medical Ethics (New Mexico Medical Board), including 16.10.8.7 and 16.10.8.8(L)
  8. [8]16.19.36 NMAC, Compounded sterile preparations
  9. [9]New Mexico Board of Pharmacy: nonresident sterile pharmacy application (2022)
  10. [10]New Mexico Drug, Device and Cosmetic Act, NMSA 1978, Chapter 26, Article 1